Cumberland Pharmaceuticals Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CPIX research report →
Companywww.cumberlandpharma.com
Cumberland Pharmaceuticals Inc. , a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.
- CEO
- A. J. Kazimi
- IPO
- 2009
- Employees
- 91
- HQ
- Nashville, TN, US
Price Chart
Valuation
- Market Cap
- $82.86M
- P/E
- -11.44
- P/S
- 1.98
- P/B
- 3.82
- EV/EBITDA
- -43.07
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 82.89%
- Op Margin
- -17.20%
- Net Margin
- -17.24%
- ROE
- -28.75%
- ROIC
- -19.50%
Growth & Income
- Revenue
- $44.52M · 17.57%
- Net Income
- $-2,836,128 · 56.23%
- EPS
- $-0.19 · 58.70%
- Op Income
- $-2,791,993
- FCF YoY
- 710.51%
Performance & Tape
- 52W High
- $6.27
- 52W Low
- $1.85
- 50D MA
- $3.70
- 200D MA
- $3.47
- Beta
- -0.06
- Avg Volume
- 993.64K
Get TickerSpark's AI analysis on CPIX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | Brown Martin S JR | other | 1,800 |
| Mar 18, 26 | Galante Joseph C | other | 1,800 |
| Mar 18, 26 | Jones James | other | 1,800 |
| Mar 18, 26 | Krogulski Kenneth | other | 4,000 |
| Mar 18, 26 | Krogulski Kenneth | other | 1,800 |
| Mar 18, 26 | Young Caroline | other | 1,800 |
| Mar 18, 26 | Anthony Todd M. | other | 3,000 |
| Mar 18, 26 | Bitterman Chris T. | other | 3,000 |
| Mar 18, 26 | Hamm John M. | other | 3,000 |
| Mar 18, 26 | Herman James L | other | 2,500 |
Our CPIX Coverage
We haven't published any research on CPIX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CPIX Report →